×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 6: Legal Types of Marketing Authorizations in the EU
Session Chair(s)
![Diptee A. Gajjar, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Diptee A. Gajjar, PhD
Intercontinental Regulatory Strategy Lead
Bristol-Myers Squibb Company, United States
- Full dossier
- Generics, abbreviated drug application
- Biosimilars
- Bibliographic application, well established use
- Combination products
- Regulatory data protection and exclusivity
- Data protection
- Market exclusivity
- Extension of supplementary protection certificate